as on March 3, 2026 at 7:59 am IST
Day's Low
10.70%
Downside
52 Week's Low
52 Week's High
50.64%
Downside
70.10%
Upside
Check Abcellera Biologics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.1B
EPS (TTM)
-0.6967
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.46%
PE Ratio (TTM)
-4.86
Industry PE ratio
-3.105112781954887
PEG Ratio
0EBITDA
-194.9M
Revenue (TTM)
75.1M
Profit Margin
-194.88%
Return On Equity TTM
-14.48%
Track how Abcellera Biologics Inc P/E has moved over time to understand its valuation trends.
Abcellera Biologics Inc in the last 5 years
Lowest (-50.45x)
March 31, 2023
Today (-4.86x)
March 3, 2026
Industry (-3.11x)
March 3, 2026
Highest (52.65x)
March 31, 2021
Today’s Price to Earnings Ratio: -4.86x
Compare market cap, revenue, PE, and other key metrics of Abcellera Biologics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $1.1B | -89.29% | -4.86 | -194.88% | |
| BUY | $126.2B | 133.18% | 32.47 | 32.94% | |
| BUY | $44.2B | 125.24% | 142.88 | 8.45% | |
| NA | $35.1B | NA | 621.55 | 5.37% | |
| BUY | $82.6B | 77.02% | 18.83 | 31.41% |
The Abcellera Biologics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Abcellera Biologics Inc investment value today
Current value as on today
₹1,67,105
Returns
₹67,105
(+67.11%)
Returns from Abcellera Biologics Inc Stock
₹62,288 (+62.29%)
Dollar Returns*
₹4,817 (+4.82%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Abcellera Biologics Inc. Average target price of $9.17
Get share price movements and forecasts by analysts on Abcellera Biologics Inc.
What analysts predicted
58.23%UPSIDE
Target Price
$9.17
Current Price
$3.83
Analyzed by
15 Analysts
Target
$9.17
Abcellera Biologics Inc target price $9.17, a slight upside of 58.23% compared to current price of $3.83. According to 15 analysts rating.
Investment in Abcellera Biologics Inc Shares on INDmoney has grown by 1.49% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:1.49% versus previous 30 day period
Search interest for Abcellera Biologics Inc Stock has decreased by -67% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
![]()
In the last 7 days, ABCL stock has moved up by 18.6%
Profit Spike
![]()
Netprofit is up for the last 2 quarters, -57.11M → -8.94M (in $), with an average increase of 538.6% per quarter
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 8.95M → 44.85M (in $), with an average increase of 80.0% per quarter
Best in 1 Year
![]()
In the last 1 year, ABCL has outperformed top 5 stocks with highest market-cap in its industry
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 60.5% return, outperforming this stock by 114.9%
| Organisation | Abcellera Biologics Inc |
| Headquarters | 150 W 4th Avenue, Vancouver, BC, Canada, V5Y 1G6 |
| Industry | Healthcare |
| CEO | Dr. Carl L.G. Hansen Ph.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Carl L.G. Hansen Ph.D. | CEO, President & Chairperson |
Mr. Tryn T. Stimart Esq., J.D., M.Sc. | Chief Legal Officer, Chief Compliance Officer, Corporate Secretary & Privacy Officer |
Mr. Andrew Booth M.B.A. | Chief Financial Officer |
Dr. Veronique Lecault Ph.D. | CTO & Director |
Mr. Andrew Knowles M.Sc. | VP of Operations |
Mr. Martin Hogan M.Sc. | Senior Director of Strategic Finance & IR |
Ms. Tiffany Chiu B.Sc., Ph.D. | Vice President of Communications |
Caitlin Webster CIPD, M.Sc. | Director of Talent Development |
Mr. Murray McCutcheon Ph.D. | Senior Vice President of Partnering |
Mr. Adam Clarke M.A.I.C.D., Ph.D. | Senior Vice President of Discovery |
Abcellera Biologics Inc share price today is $3.83 as on at the close of the market. Abcellera Biologics Inc share today touched a day high of $3.83 and a low of $3.42.
Abcellera Biologics Inc share touched a 52 week high of $6.52 on and a 52 week low of $1.89 on . Abcellera Biologics Inc stock price today i.e. is closed at $3.83,which is 41.21% down from its 52 week high and 102.58% up from its 52 week low.
Abcellera Biologics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Abcellera Biologics Inc (ABCL) shares with as little as ₹91.474 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹914.74 in Abcellera Biologics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Abcellera Biologics Inc share’s latest price of $3.83 as on March 3, 2026 at 2:29 am IST, you will get 2.6110 shares of Abcellera Biologics Inc. Learn more about
fractional shares .
Abcellera Biologics Inc stock has given -89.29% share price returns and 24.32% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?